Longenesis and Medtronic study says quality of life improves with insulin pumps

Longenesis has announced that a study on Type 1 diabetes care, undertaken in partnership with Medtronic, has demonstrated that insulin pump use supports a higher quality of life.

Across less than three months, more than 85 patients participated in the research study aimed at providing qualitative and quantitative data on the quality of life for Type 1 diabetics using insulin pumps compared to daily insulin injections.

Approximately 80% of patients in the study reviewed their participation as satisfactory, with no patients expressing dissatisfaction, according to Longenesis, with cost being the main reason given for stopping insulin pump usage, emphasising the importance of patient-centric reimbursement policies for diabetes patients.

The project findings may serve as a tool for patient advocacy groups and respective stakeholders in drawing their government’s attention to the needs of Type 1 diabetes patients in managing their care, both financially and personally.

To read more, CLICK HERE.

Desang Diabetes Magazine is our free-to-receive digital journal (see below). We cover diabetes news, diabetes management equipment (diabetes ‘kit’ such as insulin pumps and continuous glucose monitoring equipment) and news about food suitable for a diabetic diet including a regular Making Carbs Count column. We just need your email address to subscribe you (it really is free, and you can easily unsubscribe should you wish to).

Sign me up!
Open publication
Buy a Desang kitbag

See our range of kitbags